In ₹ Crore except Per Share Latest Annual | ORCHPHARMA FY26 | FDC FY26 | GUJTHEM FY26 | IOLCP FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 249.38× | ◆ 20.03× | — | 45.20× | 32.62× +665% | |
| P/B | 3.98× | ◆ 2.27× | 16.28× | 3.46× | 3.46× +15% | |
| EV/EBITDA | 133.07× | ◆ 14.79× | 64.11× | 23.37× | 23.37× +469% | |
| Market Cap | ₹5,123 Cr | ₹5,640 Cr | ₹4,685 Cr | ₹6,223 Cr | ₹5,640 Cr -9% | |
| Growth | ||||||
| Revenue CAGR 3Y | ◆ 6.81% | 6.77% | — | 1.51% | 4.14% +64% | |
| Revenue CAGR 5Y | ◆ 12.51% | 10.24% | — | — | 10.24% +22% | |
| Net Income CAGR 3Y | -23.73% | ◆ 13.23% | — | -0.36% | 6.44% -469% | |
| Revenue YoY (latest Q) | ◆ 75.89% | 2.97% | 22.07% | 37.08% | 22.07% +244% | |
| Net Income YoY (latest Q) | -78.38% | 9.18% | 22.12% | ◆ 89.80% | 22.12% -454% | |
| Profitability | ||||||
| EBITDA Margin | 5.07% | 15.94% | ◆ 45.55% | 11.60% | 15.94% -68% | |
| Net Income Margin | 2.53% | 12.96% | ◆ 28.15% | 5.94% | 12.96% -80% | |
| Return on Common Equity | 1.60% | 11.32% | ◆ 16.22% | 7.65% | 11.32% -86% | |
| Return on Capital Employed | 0.35% | 11.23% | ◆ 14.76% | 9.95% | 11.23% -97% | |
| Return on Assets | 1.08% | ◆ 9.64% | 9.27% | 5.32% | 9.27% -88% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.28× | ◆ 0.00× | 0.56× | 0.07× | 0.07× +300% | |
| Interest Coverage | 0.43× | ◆ 57.54× | 21.23× | 12.97× | 21.23× -98% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹811 Cr | ₹2,171 Cr | ₹166 Cr | ₹2,319 Cr | ₹2,171 Cr -63% | |
| Net Income | ₹20.5 Cr | ₹281 Cr | ₹46.7 Cr | ₹138 Cr | ₹138 Cr -85% | |
| Total Assets | ₹1,911 Cr | ₹2,919 Cr | ₹503 Cr | ₹2,587 Cr | ₹2,587 Cr -26% | |
| EPS | ₹4.05 | ₹17.29 | ₹0 | ₹4.69 | ₹4.69 -14% | |
| Book Value per Share | ₹253.91 | ₹152.64 | ₹26.41 | ₹61.27 | ₹61.27 +314% | |